You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Midostaurin

Showing 26 - 50 of 58
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in

No longer available
  • Acute Myeloid Leukemia (AML) With
  • FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
  • Midostaurin
  • Phoenix, Arizona
  • +43 more
Jul 14, 2020

Leukemia Trial in Canada, United States (cytarabine, daunorubicin, midostaurin)

Active, not recruiting
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +175 more
Aug 16, 2021

Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, FLT3 Tyrosine Kinase Domain Point

Terminated
Has Results
  • Acute Myeloid Leukemia With FLT3/ITD Mutation
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 17, 2019

Acute Myeloid Leukemia Trial in Austria, Germany (Midostaurin, Cytarabine, Daunorubicin)

Completed
  • Acute Myeloid Leukemia
  • Midostaurin
  • +2 more
  • Innsbruck, Austria
  • +54 more
Jun 3, 2020

Leukemia, Myeloid, Acute Trial (HDM201, cytarabine, anthracycline)

Withdrawn
  • Leukemia, Myeloid, Acute
  • (no location specified)
Jan 6, 2020

AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)

Not yet recruiting
  • AML, Adult
  • +4 more
  • Amiens, France
  • +19 more
Sep 1, 2023

Optimize Treatment Strategies for Older Hematologic Malignancies

Recruiting
  • Leukemia, Acute
  • MDS
  • Bone Marrow or Peripheral Blood Graft (BMT)
  • +2 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jan 7, 2022

Acute Myeloid Leukemia Trial (Quizartinib, Treatment according to Physician's Choice, Standard of Care Chemotherapy)

Withdrawn
  • Acute Myeloid Leukemia
  • (no location specified)
May 18, 2022

Acute Myeloid Leukemia Trial in France (Dexamethasone)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Angers, France
  • +24 more
Jul 26, 2022

Adenocarcinoma of the Rectum Trial in Boston (Midostaurin)

Completed
  • Adenocarcinoma of the Rectum
  • Midostaurin
  • Boston, Massachusetts
  • +1 more
Dec 11, 2018

Acute Myeloid Leukemia, Adult Trial in La Plata, Caba (Evaluation of first line treatment with intensive treatment outcome in

Recruiting
  • Acute Myeloid Leukemia, Adult
  • Evaluation of first line treatment with intensive treatment outcome in adult patients with AML.
  • La Plata, Buenos Aires, Argentina
  • +1 more
Nov 9, 2021

Acute Myeloid Leukemia Trial in Gainesville, Saint Louis, Rochester (drug, procedure, device)

Recruiting
  • Acute Myeloid Leukemia
  • Gainesville, Florida
  • +2 more
Aug 30, 2022

Acute Myeloid Leukemia Trial in Gainesville (Midostaurin, Cytarabine)

Withdrawn
  • Acute Myeloid Leukemia
  • Gainesville, Florida
    University of Florida
Oct 18, 2018

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Gilbert, Arizona
  • +23 more
Feb 22, 2022

Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in

Completed
Has Results
  • Systemic Mastocytosis, Aggressive (ASM)
  • +2 more
  • Midostaurin
  • Stanford, California
  • +2 more
Sep 19, 2018

Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults, AML (Adult) With 11q23

Terminated
Has Results
  • Acute Myeloid Leukemia (AML) With Multilineage Dysplasia Following Myelodysplastic Syndrome, in Adults
  • +7 more
  • Stanford, California
    Stanford University School of Medicine
Sep 25, 2018

Leukemia, Myeloid, Acute Trial in Jerusalem (Vyxeos, Mylotarg)

Recruiting
  • Leukemia, Myeloid, Acute
  • Jerusalem, Yerushalayim, Israel
    Shaare Zedek Medical Center
Oct 25, 2022

Acute Myeloid Leukemia, MDS Trial in United States (CG-806)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Duarte, California
  • +9 more
Mar 4, 2022

Leukemia Trial in Houston (5-azacytidine, PKC412)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 18, 2018

Cancer Target Therapy Efficacy

Active, not recruiting
  • Cancer
  • RNA sequencing
  • +5 more
  • Walnut, California
  • +6 more
Sep 13, 2021

Leukemia Trial in Worldwide (Midostaurin (PKC412))

Completed
Has Results
  • Leukemia
  • Midostaurin (PKC412)
  • Los Angeles, California
  • +28 more
Oct 16, 2018

Acute Myeloid Leukemia With Gene Mutations, Adult Acute Myeloid Leukemia in Remission Trial (Midostaurin)

Withdrawn
  • Acute Myeloid Leukemia With Gene Mutations
  • Adult Acute Myeloid Leukemia in Remission
  • Midostaurin
  • (no location specified)
May 1, 2018

AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

Recruiting
  • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
  • MRD-triggered arm
  • Prophylactic Arm
  • Heidelberg, BW, Germany
    University Hospital Heidelberg Med5
Jan 4, 2021

AML, Adult, MDS Trial in Lørenskog (Standard therapy, Precision therapy)

Recruiting
  • AML, Adult
  • MDS
  • Standard therapy
  • Precision therapy
  • Lørenskog, Norway
    Akershus Universitetssykehus
Aug 23, 2021

Gene Mutations in Myeloid Cancers by Next Generation Sequencing

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
    • Taipei, Taiwan
      National Taiwan University Hospital
    Aug 15, 2019